Canada's EndoCeutics Files for $75 Million US IPO

Published: Feb 28, 2007

WASHINGTON, Feb 27 (Reuters) - Canada's EndoCeutics Inc., a pharmaceutical firm developing hormone therapies for breast cancer and other endocrine-related disorders, said on Tuesday itQ is planning an initial public offering.

>>> Discuss This Story

Back to news